Stock-based Compensation Expense - Schedule of Company's Stock Option Activity (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Number of Shares Subject to Options
Beginning balance (in shares)	51,591
Granted (in shares)	0
Cancelled, forfeited, and expired (in shares)	(180)
Exercised (in shares)	(2,263)
Ending balance (in shares)	49,148	51,591
Exercisable (in shares)	40,367
Vested and expected to vest (in shares)	49,148
Weighted- Average Exercise Price (per Option)
Beginning balance, weighted average exercise price (in dollars per share)	$ 2.85
Granted, weighted average exercise price (in dollars per share)	0
Cancelled, forfeited, and expired, weighted average exercise price (in dollars per share)	4.69
Exercised, weighted average exercise price (in dollars per share)	2.61
Ending balance, weighted average exercise price (in dollars per share)	2.86	$ 2.85
Exercisable, weighted average exercise price (in dollars per share)	2.51
Vested and expected to vest, weighted average exercise price (in dollars per share)	$ 2.86
Weighted-Average Remaining Contractual Term (Years)	5 years 9 months 7 days	6 years
Exercisable, weighted-average remaining contractual term	5 years 5 months 26 days
Vested and expected to vest, weighted-average remaining contractual term	5 years 9 months 7 days
Aggregate Intrinsic Value	$ 2,070,340	$ 1,321,183
Exercisable, aggregate intrinsic value	1,714,354
Vested and expected to vest, aggregate intrinsic value	$ 2,070,340